113 related articles for article (PubMed ID: 17048274)
1. Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases.
Ghittoni R; Napolitani G; Benati D; Ulivieri C; Patrussi L; Laghi Pasini F; Lanzavecchia A; Baldari CT
Eur J Immunol; 2006 Nov; 36(11):2885-93. PubMed ID: 17048274
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin inhibits T-cell activation by selectively impairing the function of Ras superfamily GTPases.
Ghittoni R; Patrussi L; Pirozzi K; Pellegrini M; Lazzerini PE; Capecchi PL; Pasini FL; Baldari CT
FASEB J; 2005 Apr; 19(6):605-7. PubMed ID: 15677697
[TBL] [Abstract][Full Text] [Related]
3. Contrasting cytoskeletal regulation of MHC class II peptide presentation by human B cells or dendritic cells.
Delaguillaumie A; Marin-Esteban V; Setterblad N; Leh LJ; Assier E; Gelin C; Charron D; Galy A; Mooney N
Eur J Immunol; 2008 Apr; 38(4):1096-105. PubMed ID: 18393378
[TBL] [Abstract][Full Text] [Related]
4. The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation.
Vascotto F; Lankar D; Faure-André G; Vargas P; Diaz J; Le Roux D; Yuseff MI; Sibarita JB; Boes M; Raposo G; Mougneau E; Glaichenhaus N; Bonnerot C; Manoury B; Lennon-Duménil AM
J Cell Biol; 2007 Mar; 176(7):1007-19. PubMed ID: 17389233
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C delta stimulates antigen presentation by Class II MHC in murine dendritic cells.
Majewski M; Bose TO; Sillé FC; Pollington AM; Fiebiger E; Boes M
Int Immunol; 2007 Jun; 19(6):719-32. PubMed ID: 17446207
[TBL] [Abstract][Full Text] [Related]
6. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation.
Anderson HA; Hiltbold EM; Roche PA
Nat Immunol; 2000 Aug; 1(2):156-62. PubMed ID: 11248809
[TBL] [Abstract][Full Text] [Related]
7. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K
Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052
[TBL] [Abstract][Full Text] [Related]
8. Location of major histocompatibility complex class II molecules in rafts on dendritic cells enhances the efficiency of T-cell activation and proliferation.
Eren E; Yates J; Cwynarski K; Preston S; Dong R; Germain C; Lechler R; Huby R; Ritter M; Lombardi G
Scand J Immunol; 2006 Jan; 63(1):7-16. PubMed ID: 16398696
[TBL] [Abstract][Full Text] [Related]
9. Calmodulin kinase II regulates the maturation and antigen presentation of human dendritic cells.
Herrmann TL; Morita CT; Lee K; Kusner DJ
J Leukoc Biol; 2005 Dec; 78(6):1397-407. PubMed ID: 16204647
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of protein geranylgeranylation specifically interferes with CD40-dependent B cell activation, resulting in a reduced capacity to induce T cell immunity.
Shimabukuro-Vornhagen A; Zoghi S; Liebig TM; Wennhold K; Chemitz J; Draube A; Kochanek M; Blaschke F; Pallasch C; Holtick U; Scheid C; Theurich S; Hallek M; von Bergwelt-Baildon MS
J Immunol; 2014 Nov; 193(10):5294-305. PubMed ID: 25311809
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
Lee MH; Cho YS; Han YM
Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of endogenous MHC class II-restricted antigen presentation by tacrolimus (FK506) via FKBP51.
Imai A; Sahara H; Tamura Y; Jimbow K; Saito T; Ezoe K; Yotsuyanagi T; Sato N
Eur J Immunol; 2007 Jul; 37(7):1730-8. PubMed ID: 17523132
[TBL] [Abstract][Full Text] [Related]
13. B-cell antigen receptor signaling requirements for targeting antigen to the MHC class II presentation pathway.
Clark MR; Massenburg D; Siemasko K; Hou P; Zhang M
Curr Opin Immunol; 2004 Jun; 16(3):382-7. PubMed ID: 15134789
[TBL] [Abstract][Full Text] [Related]
14. CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells.
Kuwano Y; Prazma CM; Yazawa N; Watanabe R; Ishiura N; Kumanogoh A; Okochi H; Tamaki K; Fujimoto M; Tedder TF
Int Immunol; 2007 Aug; 19(8):977-92. PubMed ID: 17804692
[TBL] [Abstract][Full Text] [Related]
15. Application of specific cell permeable cathepsin G inhibitors resulted in reduced antigen processing in primary dendritic cells.
Reich M; Lesner A; Legowska A; Sieńczyk M; Oleksyszyn J; Boehm BO; Burster T
Mol Immunol; 2009 Sep; 46(15):2994-9. PubMed ID: 19615749
[TBL] [Abstract][Full Text] [Related]
16. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
17. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
Dobaño C; Rogers WO; Gowda K; Doolan DL
Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
19. Statins affect cell-surface expression of major histocompatibility complex class II molecules by disrupting cholesterol-containing microdomains.
Kuipers HF; Biesta PJ; Groothuis TA; Neefjes JJ; Mommaas AM; van den Elsen PJ
Hum Immunol; 2005 Jun; 66(6):653-65. PubMed ID: 15993711
[TBL] [Abstract][Full Text] [Related]
20. Endogenous presentation of a nuclear antigen on MHC class II by autophagy in the absence of CRM1-mediated nuclear export.
Riedel A; Nimmerjahn F; Burdach S; Behrends U; Bornkamm GW; Mautner J
Eur J Immunol; 2008 Aug; 38(8):2090-5. PubMed ID: 18624354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
